STOCK TITAN

Mitesco Inc SEC Filings

MITI OTC Link

Welcome to our dedicated page for Mitesco SEC filings (Ticker: MITI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Mitesco, Inc. (MITI) files a range of SEC documents that provide detailed insight into its business evolution, capital structure and technology-focused strategy. Its registration statements on Form S‑1 and S‑1/A describe Mitesco as a smaller reporting company incorporated in Nevada, outline its history from earlier business lines through the closure of The Good Clinic operations, and explain its current emphasis on data center and cloud computing activities through its Centcore unit, along with venture and software initiatives under Vero Technology Ventures.

These S‑1 filings also register shares of common stock for resale by selling stockholders, including shares issued in connection with the restructuring of promissory notes, accounts payable and preferred stock, as well as shares issuable upon redemption or conversion of Series A Amortizing Convertible Preferred Stock and bridge notes. The prospectus sections discuss risk factors, use of proceeds for selling stockholders, and the company’s status as a smaller reporting company whose common stock trades on the OTC‑QB Venture Market under the symbol MITI.

Mitesco’s current reports on Form 8‑K and 8‑K/A add further detail on material events and securities issuances. These filings describe the creation and terms of the Series A Amortizing Convertible Preferred Stock, dividend payments on Series X Preferred Stock in restricted common shares, redemptions and conversions of preferred stock, and the issuance of common shares to consultants involved in developing the company’s Robo Agent software application. Other 8‑K filings disclose senior secured convertible bridge notes, advisory agreements related to potential uplisting of the company’s securities, and press releases about expansion plans and data center initiatives.

Through Stock Titan’s SEC filings page, users can access these documents as they are made available on EDGAR and review them alongside AI-powered summaries that highlight key terms, structural changes and business descriptions. Investors can quickly locate Mitesco’s annual and quarterly reports, registration statements, and current reports, as well as disclosures about preferred stock structures, insider-related equity issuances and financing arrangements. This consolidated view helps readers understand how Mitesco’s regulatory filings reflect its shift toward data center services, cloud computing ventures and A.I.-enabled software, while also tracking the company’s ongoing restructuring of legacy obligations.

Rhea-AI Summary

Mitesco, Inc. entered into a six‑month Advisory Agreement with JRB Consulting, Inc. to support acquisitions, financing efforts, and an uplisting of its securities to a senior exchange such as NASDAQ or the NYSE. As compensation, Mitesco will pay JRB a cash fee of $200,000 upon completion of an approved uplisting and has immediately issued 250,000 shares of restricted common stock, which will be included on a piggyback basis in a future registration statement.

The company states that the shares were issued to accredited institutional investors in a private transaction under Section 4(a)(2) of the Securities Act. Mitesco also released a press update describing its enterprise AI sales‑force automation application called “Robo Agent”, its goal of moving to a senior trading exchange, and the possibility of pursuing a merger or acquisition to accelerate growth beyond organic expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Mitesco, Inc. filed its Q3 2025 report, showing severe liquidity and ongoing restructuring. The company ended the quarter with cash and cash equivalents of $321 and a stockholders’ equity deficit of $(23,785,020). Management disclosed “substantial doubt” about its ability to continue as a going concern.

Q3 revenue was $3,000 (down from $23,500 a year ago) as resources shifted to software projects. Operating expenses were $1,014,422, and the company reported a Q3 net loss of $(3,202,971), driven by accretion and revaluations tied to its Series A preferred and a $(500,000) legal settlement loss. For the nine months, revenue was $38,700 and net income was $159,981, aided by a $3,513,655 gain on derivative revaluation.

Current liabilities totaled $17,583,270, including legal settlements of $3,322,834 and Series A preferred liabilities presented at a $13,397,721 present value. The company issued common shares for redemptions and services and recorded stock-based compensation of $824,649 year-to-date. As of November 13, 2025, common shares outstanding were 15,093,055.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Mitesco, Inc. (MITI) entered a secured financing and unregistered equity securities transaction. The company issued a Senior Secured 10% Original Issue Discount Convertible Promissory Note with potential total funding of $1,000,000, beginning with $250,000 funded on October 31, 2025. The 18‑month note requires repayment of $275,000 reflecting the 10% OID, bears no interest unless in default, and is convertible into common stock at $0.15 per share, subject to adjustments.

The note may be prepaid at 110% of the outstanding principal. Obligations are guaranteed by subsidiaries, secured by a pledge of subsidiary securities, and carry a first‑priority senior security interest in all company assets. The securities were sold pursuant to Section 4(a)(2) and Regulation D and are not registered under the Securities Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Mitesco, Inc. (MITI) reported an insider transaction by CEO and director Mack R. Leath. On 09/22/2025, Leath acquired 8,787 shares of common stock at $0.18 per share. Following this trade, he beneficially owned 394,327 shares, held directly. A footnote states this total includes 100,000 shares held by a family member.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Mitesco, Inc. reports multiple unregistered issuances of equity tied to preferred stock obligations and consultant compensation. The company paid Q3 FY2025 dividends on its Series X Preferred Stock, which has 42,103 shares outstanding with a total face value of $1,052,575 and a 10% annual rate, by issuing 99,338 restricted common shares to several holders.

During Q3, Mitesco redeemed $257,700 of its Series A Amortizing Convertible Preferred Stock by issuing 2,025,910 common shares under terms that allow cash or stock redemptions and include a 4.9% ownership cap per holder. This reduced the remaining stated value of the Series A Preferred Stock to $13,591,200, and the company is in discussions with holders about changing or possibly eliminating this class before December 31, 2025.

The company also issued 725,000 restricted common shares to four consultants, including its CTO, as consideration for software development work on its Robo Agent application. All equity issuances were made to accredited investors in private offerings, and total common shares outstanding after these transactions are approximately 14,593,055.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Mitesco, Inc. reports several unregistered equity issuances, preferred stock redemptions, and a business update press release. The company issued 99,338 restricted common shares as Q3 FY2025 dividends on its Series X Preferred Stock, which totals 42,103 shares with a face value of $1,052,575 and a 10% annual rate. It also issued 2,025,910 common shares to redeem $257,700 of its Series A Amortizing Convertible Preferred Stock during Q2, leaving $13,591,200 of stated value outstanding. In addition, 725,000 restricted common shares were granted to four consultants, including the CTO, for Robo Agent software development. After these transactions, total common shares outstanding are approximately 14,593,055, and the company is discussing potential changes or elimination of the Series A Preferred Stock, which it expects may occur before December 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Mitesco (MITI)?

The current stock price of Mitesco (MITI) is $0.119792 as of March 10, 2026.

What is the market cap of Mitesco (MITI)?

The market cap of Mitesco (MITI) is approximately 3.1M.

MITI Rankings

MITI Stock Data

3.13M
15.81M
Health Information Services
Healthcare
Link
United States
Vero Beach

MITI RSS Feed